abstract |
A cyclic peptide that can specifically bind to the α2I domain of the collagen-binding integrin receptor can bind to the drug-containing particle via a linker moiety. The conjugates can be used to target therapeutic agents to cells that have collagen-bound integrin receptors expressed on their surface. |